Telluride Asset Management’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Telluride Asset Management’s Portfolio AMPE Stock Details AMPE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	$121K	Buy	+48	New	+$98K	0.1%	223

Other funds holding AMPE

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Talkot Capital Sausalito, California $73.7M AUM 8.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Telluride Asset Management's AMPE Position: Q2 2014 in Review

Telluride Asset Management opened a new position in Ampio Pharmaceuticals Inc. (AMPE) in Q2 2014: 48 shares worth $121K. The stake represents 0.1% of the portfolio and ranks #223 among its holdings.

75 funds tracked by Wall St. Rank hold AMPE as of Q2 2014.

Telluride Asset Management held 48 shares of Ampio Pharmaceuticals Inc. worth $121K as of Q2 2014.
Ampio Pharmaceuticals Inc. was a new Telluride Asset Management position in Q2 2014.
Ampio Pharmaceuticals Inc. made up 0.1% of Telluride Asset Management's portfolio in Q2 2014, its #223 holding.
75 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q2 2014.

Based on Telluride Asset Management's 13F filing for Q2 2014, filed 14 Aug 2014.